abrdn Healthcare Investors
HQH- Exchange
- NYSE
- SEC CIK
- 0000805267
In the last 90 days, abrdn Healthcare Investors insiders filed 1 open-market purchase and 0 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $293.0M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in abrdn Healthcare Investors as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 115
- 0 vs. Q2 2023
- Shares held
- 10.3M
- +994.7K (+10.7%) vs. Q2 2023
- Total value
- $160.3M
- +$1.44M (+0.9%) vs. Q2 2023
- New holders
- 10
- 47 more added
- Sold out
- 10
- 33 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HQH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 125 | $293.0M |
| Q1 2026 | 128 | $231.8M |
| Q4 2025 | 123 | $247.6M |
| Q3 2025 | 120 | $222.6M |
| Q2 2025 | 114 | $180.4M |
| Q1 2025 | 106 | $192.1M |
| Q4 2024 | 119 | $196.7M |
| Q3 2024 | 121 | $243.8M |
| Q2 2024 | 113 | $222.3M |
| Q1 2024 | 120 | $216.8M |
| Q4 2023 | 123 | $208.1M |
| Q3 2023 | 115 | $160.3M |
| Q2 2023 | 116 | $158.9M |
| Q1 2023 | 118 | $153.2M |
| Q4 2022 | 114 | $153.9M |
| Q3 2022 | 105 | $141.9M |
| Q2 2022 | 104 | $149.2M |
| Q1 2022 | 99 | $167.5M |
| Q4 2021 | 104 | $196.1M |
| Q3 2021 | 102 | $220.5M |
| Q2 2021 | 113 | $226.9M |
| Q1 2021 | 114 | $236.0M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding abrdn Healthcare Investors; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Raymond James & Associates | 170,957 | $2.66M | 0.00% | +10,033+6.2% | Added |
| UBS Group AG | 189,978 | $2.95M | 0.00% | −18,159−8.7% | Reduced |
| LPL Financial LLC | 203,705 | $3.17M | 0.00% | −53,705−20.9% | Reduced |
| Bank of America Corp | 205,517 | $3.20M | 0.00% | +20,101+10.8% | Added |
| Needham Investment Management LLC | 226,965 | $3.53M | 0.60% | +5,684+2.6% | Added |
| Raymond James Financial Services Advisors, Inc. | 239,155 | $3.72M | 0.01% | −7,878−3.2% | Reduced |
| Advisor Group Holdings, Inc. | 256,548 | $3.99M | 0.01% | +99,280+63.1% | Added |
| Logan Stone Capital, LLC | 275,281 | $4.28M | 1.17% | +170,415+162.5% | Added |
| Saba Capital Management, L.P. | 296,637 | $4.61M | 0.15% | +168,402+131.3% | Added |
| CNH Partners LLC | 319,150 | $4.96M | 0.22% | +177,748+125.7% | Added |
| Wolverine Asset Management LLC | 355,201 | $5.52M | 0.10% | +95,038+36.5% | Added |
| Rpo LLC | 376,791 | $5.86M | 9.99% | +121,018+47.3% | Added |
| Cornerstone Advisors, LLC | 439,379 | $6.83M | 0.32% | +154,220+54.1% | Added |
| Royal Bank of Canada | 450,457 | $7.00M | 0.00% | −80,645−15.2% | Reduced |
| Morgan Stanley | 3,226,273 | $50.2M | 0.01% | +26,809+0.8% | Added |
| Karpus Management, Inc. | 0 | $0 | 0.00% | −85,634−100.0% | Sold out |
| U.S. Capital Wealth Advisors, LLC | 0 | $0 | 0.00% | −32,360−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −12,954−100.0% | Sold out |
| D.A. Davidson & Co. | 0 | $0 | 0.00% | −10,940−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,494−100.0% | Sold out |
| Impact Partnership Wealth, LLC | 0 | $0 | 0.00% | −724−100.0% | Sold out |
| Sittner & Nelson, LLC | 0 | $0 | 0.00% | −575−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| St Germain D J Co Inc | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Piershale Financial Group, Inc. | – | – | – | – | Not filed |